Frequently Asked Questions
The market is segmented based on Global PET Nuclear Medicine Market, By Type (F-18, Rb-82, and Others), Application (Oncology, Cardiology, Neurology, and Other PET Applications), Procedure (Diagnostic Procedures and Therapeutic Procedures), End User (Hospitals and Diagnostic Centers and Research Institutes) – Industry Trends and Forecast to 2031.
.
The Global Pet Nuclear Medicine Market size was valued at USD 9.00 USD Billion in 2021.
The Global Pet Nuclear Medicine Market is projected to grow at a CAGR of 15% during the forecast period of 2022 to 2029.
The major players operating in the market include Cardinal Health, General Electric, Lantheus, Bayer AG, Bracco Diagnostic , NorthStar Medical Radioisotopes LLC, Eckert & Ziegler, Jubilant DraxImage , PharmaLogic Holdings Corp., Institute of Isotopes Co., SHINE Medical Technologies LLC, Global Medical Solutions LLC, Segami Corporation, Spectrum Dynamics Medical, CMR Naviscan, Shanghai United Imaging Healthcare Co. Ltd, Neusoft Corporation.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
